Guardant Health (GH) Shares Outstanding (2017 - 2026)

Guardant Health has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $133.6 million in Q2 2026.

• Quarterly Shares Outstanding (Entity) rose 6.5% year-over-year to $133.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $133.6 million (up 6.5% YoY) and the FY2025 annual result came in at $130.6 million, up 5.36% from the prior year.
• Shares Outstanding (Entity) climbed to $133.6 million in Q2 2026 per GH's latest filing, from $131.5 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $133.6 million in Q2 2026 and troughed at $101.9 million in Q1 2022.
• A 5-year average of $118.5 million and a median of $122.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) advanced 0.78% in 2022, then climbed 18.58% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $102.6 million in 2022, then grew by 18.53% to $121.6 million in 2023, then rose by 1.94% to $124.0 million in 2024, then advanced by 5.36% to $130.6 million in 2025, then rose by 2.28% to $133.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $133.6 million, $131.5 million, and $130.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.